Midcentral District Health Board

Palmerston North 4442

0 studies enrolling now · 2 studies all time

What they study most

Lymphocytic Leukemia, Chronic, Myelodysplastic Syndromes

Studies at this site

• Comparison of the Treatments of Obinutuzumab + Venetoclax Versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic Leukemia — Completed
• Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS) — Stopped early